Amarin

$4.98
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (+0.20%) Today
-$0.04 (-0.80%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Amarin and other stocks, options, and ETFs commission-free!

About AMRN

Amarin Corporation plc, also called Amarin, is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids.

CEO
John F. Thero
Employees
1,000
Headquarters
Dublin, Dublin
Founded
1989
Market Cap
2.26B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
7.47M
High Today
$5.07
Low Today
$4.86
Open Price
$5.04
Volume
4.41M
52 Week High
$9.25
52 Week Low
$3.36

AMRN News

BenzingaApr 13

The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 12) 180 Life

AMRN Earnings

-$0.07
-$0.04
-$0.01
$0.02
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Apr 27, After Hours

You May Also Like

LDRS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure